A New hybrid radiotherapy technique for non-small cell lung cancer: Is more effective for functional lung sparing

被引:0
|
作者
Chen, C. [1 ]
Chen, G. [1 ]
Fang, R. [1 ]
Xu, Y. [1 ]
Liu, H. [1 ]
Liao, Z. [1 ]
机构
[1] Wuhan Univ, Zhongnan Hosp, Hubei Canc Clin Study Ctr, Hubei Key Lab Tumor Biol Behav,Dept Radiat & Med O, Wuhan 430071, Hubei, Peoples R China
来源
INTERNATIONAL JOURNAL OF RADIATION RESEARCH | 2024年 / 22卷 / 03期
关键词
carcinoma; three dimensional conformal; radiotherapy; intensity-modulated; MODULATED RADIATION-THERAPY; ARC THERAPY; IMAGE REGISTRATION; VENTILATION; PNEUMONITIS; IMRT; VMAT; REDUCTION;
D O I
10.61186/ijrr.22.3.609
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Background: The Conventional thoracic radiotherapy planning ignores regional pulmonary function changes. This study aimed to evaluate the beneficial effect of a new hybrid three-dimensional conformal radiation therapy (3DCRT)/intensitymodulated radiation therapy (IMRT) technique. Materials and Methods: Thirty patients with non-small cell lung cancer were included in this study. Four protocols were designed for each patient: anatomical IMRT (A-IMRT, based on the total lung), functional IMRT (F-IMRT), pure IMRT (O-IMRT) plan, and hybrid 3DCRT/IMRT plan (H3DCRT/IMRT), which were based on the functional lung. The opposing pair of fields in the O-IMRT and H-3DCRT/IMRT protocols provide 2/9 and 1/2 of radiation dose, respectively. The planning target volume coverage, dose in both total and functional lungs, maximum spinal cord dose, mean esophagus dose, mean heart dose, homogeneity index (HI), conformity index (CI), and treatment monitor units (MUs) were compared in this study. Results: The V5, V20, and mean dose (Dmean) of the both total and functional lungs in the H-3DCRT/IMRT protocol were the lowest among the four treatment regimes. For D2, D98, HI, and CI, the A-IMRT protocol was superior to the H-3DCRT/IMRT protocol. Compared with the A-IMRT protocol, the F-IMRT protocol achieved significantly lower V5, V20, and Dmean for functional lungs, but showed worse HI, CI, and maximum dose of spinal cord. The H-3DCRT/IMAT protocol significantly reduced the maximum spinal cord dose and MUs. Conclusions: The H-3DCRT/IMAT plan based on functional lung images appeared to be better than conventional F-IMRT in preserving functional lung without compromising on HI and CI in NSCLC patients.
引用
收藏
页码:609 / 616
页数:8
相关论文
共 50 条
  • [21] Radiotherapy for non-metastatic non-small cell lung cancers
    Lartigau, Eric Felix
    Le Tinier, Florence
    Gaye, Elisabeth
    Dansin, Eric
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2025, 209 (02): : 275 - 279
  • [22] Sequential chemo-radiotherapy in non-small cell lung cancer
    Kotas, M
    Willner, J
    Flentje, M
    LUNG CANCER, 2001, 33 : S61 - S64
  • [23] Local ablative radiotherapy for oligometastatic non-small cell lung cancer
    Suh, Yang-Gun
    Cho, Jaeho
    RADIATION ONCOLOGY JOURNAL, 2019, 37 (03): : 149 - 155
  • [24] International Patterns of Radiotherapy Practice for Non-Small Cell Lung Cancer
    Vinod, Shalini K.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S448 - S448
  • [25] Radiotherapy for oligometastatic non-small cell lung cancer: a narrative review
    Sundahl, Nora
    Lievens, Yolande
    TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (07) : 3420 - 3431
  • [26] Combined chemotherapy and radiotherapy in inoperable non-small cell lung cancer
    Jassem, J
    LUNG CANCER, 2002, 38 : S43 - S46
  • [27] Motion Management for Radical Radiotherapy in Non-small Cell Lung Cancer
    Cole, A. J.
    Hanna, G. G.
    Jain, S.
    O'Sullivan, J. M.
    CLINICAL ONCOLOGY, 2014, 26 (02) : 67 - 80
  • [28] Immobilization devices in conformal radiotherapy for non-small cell lung cancer
    Mirimanoff, RO
    TREATMENT OPTIMIZATION FOR LUNG CANCER: FROM CLASSICAL TO INNOVATIVE PROCEDURES, 1998, : 103 - 108
  • [29] Non-small cell lung cancer
    Adamietz, I. A.
    Niederle, N.
    ONKOLOGE, 2010, 16 (06): : 63 - 74
  • [30] International consensus on radiotherapy in metastatic non-small cell lung cancer
    Zhu, Zhengfei
    Ni, Jianjiao
    Cai, Xuwei
    Su, Shengfa
    Zhuang, Hongqing
    Yang, Zhenzhou
    Chen, Ming
    Ma, Shenglin
    Xie, Conghua
    Xu, Yaping
    Li, Jiancheng
    Ge, Hong
    Liu, Anwen
    Zhao, Lujun
    Rao, Chuangzhou
    Xie, Congying
    Bi, Nan
    Hui, Zhouguang
    Zhu, Guangying
    Yuan, Zhiyong
    Wang, Jun
    Zhao, Lina
    Zhou, Wei
    Rim, Chai Hong
    Navarro-Martin, Arturo
    Vanneste, Ben G. L.
    De Ruysscher, Dirk
    Choi, J. Isabelle
    Jassem, Jacek
    Chang, Joe Y.
    Kepka, Lucyna
    Kasmann, Lukas
    Milano, Michael T.
    Van Houtte, Paul
    Suwinski, Rafal
    Traverso, Alberto
    Doi, Hiroshi
    Suh, Yang-Gun
    Noel, Georges
    Tomita, Natsuo
    Kowalchuk, Roman O.
    Sio, Terence T.
    Li, Baosheng
    Lu, Bing
    Fu, Xiaolong
    TRANSLATIONAL LUNG CANCER RESEARCH, 2022, : 1763 - 1795